Skip to main content
Top
Published in: Netherlands Heart Journal 7-8/2016

Open Access 01-07-2016 | Original Article - E‑Learning

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation

Authors: M. Verdoia, A. Schaffer, L. Barbieri, G. Di Giovine, G. Bellomo, P. Marino, H. Suryapranata, G. De Luca

Published in: Netherlands Heart Journal | Issue 7-8/2016

Login to get access

Abstract

Background

Pro-thrombotic conditions importantly influence myocardial perfusion and procedural results after percutaneous coronary intervention (PCI). The neutrophil-to-lymphocyte ratio (NLR) has emerged as a predictor of cardiovascular events and of long-term prognosis, especially in ST-elevation myocardial infarction patients undergoing primary PCI. The aim of our study was to evaluate the role of NLR on periprocedural myocardial infarction (MI) in patients undergoing non-urgent PCI.

Methods

In a consecutive cohort of 1542 patients undergoing PCI, myonecrosis biomarkers were determined at 6, 12, 24 and 48 hours post-procedure. Patients were divided into quintiles according to NLR values. Periprocedural myonecrosis was defined as a troponin I increase of 3 times the upper limit of normal or as 50 % of an elevated baseline value, whereas periprocedural MI was defined as a CK-MB increase of 3 times the upper limit of normal or 50 % of baseline.

Results

Higher NLR was related to age, established risk factors and cardiovascular history. NLR was associated with severe coronary artery disease (p = 0.009), tighter stenosis (p < 0.001), coronary calcifications (p = 0.005), intracoronary thrombus or thrombectomy use (p < 0.001), TIMI flow pre- and post-PCI (p < 0.001), and inversely to restenosis (p = 0.04) and use of a drug-eluting stent (p = 0.001). NLR did not influence the occurrence of myonecrosis (p = 0.75; adjusted OR (95 % CI) = 0.99 (0.63–1.54), p = 0.96), but was associated with a higher occurrence of periprocedural MI, even after correction for baseline differences (p = 0.03; adjusted OR (95 % CI) = 1.33 (1.02–2.3), p = 0.02), with NLR ≥ 3 best predicting the risk of periprocedural MI at the receiver operating characteristic curve analysis.

Conclusion

In patients undergoing non-urgent PCI, a higher NLR increases the risk of periprocedural MI, especially for values ≥ 3.
Literature
1.
go back to reference Navarese EP, Luca G de, Castriota F, et al. Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost. 2011;9:1902–1915.CrossRefPubMed Navarese EP, Luca G de, Castriota F, et al. Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost. 2011;9:1902–1915.CrossRefPubMed
2.
go back to reference Luca G de, Smit JJ, Ernst N, et al. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost. 2005;93:820–823.PubMed Luca G de, Smit JJ, Ernst N, et al. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost. 2005;93:820–823.PubMed
3.
go back to reference Capozzolo C, Piscione F, Luca G de, et al. Direct coronary stenting: effect on coronary blood flow, immediate and late clinical results. Catheter Cardiovasc Interv. 2001;53:464–473.CrossRefPubMed Capozzolo C, Piscione F, Luca G de, et al. Direct coronary stenting: effect on coronary blood flow, immediate and late clinical results. Catheter Cardiovasc Interv. 2001;53:464–473.CrossRefPubMed
4.
go back to reference Cuculi F, Lim CC, Banning AP. Periprocedural myocardial injury during elective coronary intervention: is it important and how can it be prevented? Heart. 2010;96:736–740.CrossRefPubMed Cuculi F, Lim CC, Banning AP. Periprocedural myocardial injury during elective coronary intervention: is it important and how can it be prevented? Heart. 2010;96:736–740.CrossRefPubMed
5.
go back to reference Hanna EB, Hennebry TA. Periprocedural myocardial infarction: review and classification. Clin Cardiol. 2010;33:476–483.CrossRefPubMed Hanna EB, Hennebry TA. Periprocedural myocardial infarction: review and classification. Clin Cardiol. 2010;33:476–483.CrossRefPubMed
6.
go back to reference Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 2000;85:50b–60b.CrossRefPubMed Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 2000;85:50b–60b.CrossRefPubMed
7.
go back to reference Shah N, Parikh V, Patel N, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171:390–397.CrossRefPubMed Shah N, Parikh V, Patel N, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014;171:390–397.CrossRefPubMed
8.
go back to reference Park BJ, Shim JY, Lee HR, et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta. 2011;412:925–929.CrossRefPubMed Park BJ, Shim JY, Lee HR, et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta. 2011;412:925–929.CrossRefPubMed
9.
go back to reference Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography – the growing versatility of NLR. Atherosclerosis. 2013;228:44–45.CrossRefPubMed Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography – the growing versatility of NLR. Atherosclerosis. 2013;228:44–45.CrossRefPubMed
10.
go back to reference Yilmaz M, Tenekecioglu E, Arslan B, et al. White Blood Cell Subtypes and Neutrophil-Lymphocyte Ratio in Prediction of Coronary Thrombus Formation in Non-ST-Segment Elevated Acute Coronary Syndrome. Clin Appl Thromb Hemost. 2015;21:446–452.CrossRefPubMed Yilmaz M, Tenekecioglu E, Arslan B, et al. White Blood Cell Subtypes and Neutrophil-Lymphocyte Ratio in Prediction of Coronary Thrombus Formation in Non-ST-Segment Elevated Acute Coronary Syndrome. Clin Appl Thromb Hemost. 2015;21:446–452.CrossRefPubMed
11.
go back to reference Sawant AC, Adhikari P, Narra SR, et al. Neutrophil to lymphocyte ratio predicts short and long term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500–508.CrossRefPubMed Sawant AC, Adhikari P, Narra SR, et al. Neutrophil to lymphocyte ratio predicts short and long term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500–508.CrossRefPubMed
12.
go back to reference Han YC, Yang TH, Kim DI, et al. Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J. 2013;43:93–99.CrossRefPubMedPubMedCentral Han YC, Yang TH, Kim DI, et al. Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J. 2013;43:93–99.CrossRefPubMedPubMedCentral
13.
go back to reference Luca G de, Santagostino M, Secco GG, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206:292–297.CrossRefPubMed Luca G de, Santagostino M, Secco GG, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206:292–297.CrossRefPubMed
14.
go back to reference Luca G de, Secco GG, Santagostino M, et al. Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis. 2012;22:426–433.CrossRefPubMed Luca G de, Secco GG, Santagostino M, et al. Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis. 2012;22:426–433.CrossRefPubMed
15.
go back to reference Luca G de, Cassetti E, Verdoia M, Marino P. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials. Thromb Haemost. 2009;102:428–436.PubMed Luca G de, Cassetti E, Verdoia M, Marino P. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials. Thromb Haemost. 2009;102:428–436.PubMed
16.
go back to reference Postma S, Dambrink JH, Boer MJ de, et al. The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients. Neth Heart J. 2014;22:513–519.CrossRefPubMedPubMedCentral Postma S, Dambrink JH, Boer MJ de, et al. The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients. Neth Heart J. 2014;22:513–519.CrossRefPubMedPubMedCentral
17.
go back to reference Luca G de, Ernst N, van’t Hof AW, et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J. 2006;151:1256–1259.CrossRefPubMed Luca G de, Ernst N, van’t Hof AW, et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J. 2006;151:1256–1259.CrossRefPubMed
18.
go back to reference Luca G de, Małek LA, Maciejewski P, et al. STEMI 2003 Registry Collaborators. Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry. Atherosclerosis. 2010;210:516–520.CrossRefPubMed Luca G de, Małek LA, Maciejewski P, et al. STEMI 2003 Registry Collaborators. Impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry. Atherosclerosis. 2010;210:516–520.CrossRefPubMed
19.
go back to reference Luca G de, Gibson CM, Bellandi F, et al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb–IIIa inhibitors. Atherosclerosis. 2009;207:181–185.CrossRefPubMed Luca G de, Gibson CM, Bellandi F, et al. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb–IIIa inhibitors. Atherosclerosis. 2009;207:181–185.CrossRefPubMed
20.
go back to reference Luca G de, Ernst N, Suryapranata H, et al. Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty. Am J Cardiol. 2005;95:1361–1363.CrossRefPubMed Luca G de, Ernst N, Suryapranata H, et al. Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty. Am J Cardiol. 2005;95:1361–1363.CrossRefPubMed
21.
go back to reference Rasoul S, Ommen V van, Vainer J, et al. Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis. Neth Heart J. 2015;23:224–231.CrossRefPubMedPubMedCentral Rasoul S, Ommen V van, Vainer J, et al. Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis. Neth Heart J. 2015;23:224–231.CrossRefPubMedPubMedCentral
22.
go back to reference Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027–1032.CrossRefPubMed Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027–1032.CrossRefPubMed
23.
go back to reference Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 1997;96:396–399.CrossRefPubMed Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 1997;96:396–399.CrossRefPubMed
24.
go back to reference Becatti M, Fiorillo C, Gori AM, et al. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. Atherosclerosis. 2013;231:392–400.CrossRefPubMed Becatti M, Fiorillo C, Gori AM, et al. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. Atherosclerosis. 2013;231:392–400.CrossRefPubMed
25.
26.
go back to reference Prasad A, Stone GW, Stuckey TD, et al. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol. 2007;99:1067–1071.CrossRefPubMed Prasad A, Stone GW, Stuckey TD, et al. Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. Am J Cardiol. 2007;99:1067–1071.CrossRefPubMed
27.
go back to reference Husser O, Bodi V, Sanchis J, et al. White blood cell subtypes after STEMI: temporal evolution, association with cardiovascular magnetic resonance-derived infarct size and impact on outcome. Inflammation. 2011;34:73–84.CrossRefPubMed Husser O, Bodi V, Sanchis J, et al. White blood cell subtypes after STEMI: temporal evolution, association with cardiovascular magnetic resonance-derived infarct size and impact on outcome. Inflammation. 2011;34:73–84.CrossRefPubMed
28.
go back to reference Cantor H, Simpson E. Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice. Eur J Immunol. 1975;5:330–336.CrossRefPubMed Cantor H, Simpson E. Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice. Eur J Immunol. 1975;5:330–336.CrossRefPubMed
29.
go back to reference Duffy BK, Gurm HS, Rajagopal V, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–996.CrossRefPubMed Duffy BK, Gurm HS, Rajagopal V, et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–996.CrossRefPubMed
30.
go back to reference Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653–657.CrossRefPubMed Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653–657.CrossRefPubMed
31.
go back to reference Ergelen M, Uyarel H, Altay S, et al. Predictive Value of Elevated Neutrophil to Lymphocyte Ratio in Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2014;20:427–432.CrossRefPubMed Ergelen M, Uyarel H, Altay S, et al. Predictive Value of Elevated Neutrophil to Lymphocyte Ratio in Patients Undergoing Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2014;20:427–432.CrossRefPubMed
32.
go back to reference Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;110:621–627.CrossRefPubMed Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;110:621–627.CrossRefPubMed
33.
go back to reference Soylu K, Yuksel S, Gulel O, et al. The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. J Thorac Dis. 2013;5:258–264.PubMedPubMedCentral Soylu K, Yuksel S, Gulel O, et al. The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. J Thorac Dis. 2013;5:258–264.PubMedPubMedCentral
34.
go back to reference Sardella G, Lucisano L, Mancone M, et al. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial. Int J Cardiol. 2013;168:3715–3720.CrossRefPubMed Sardella G, Lucisano L, Mancone M, et al. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial. Int J Cardiol. 2013;168:3715–3720.CrossRefPubMed
35.
go back to reference Leoncini M, Toso A, Maioli M, et al. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Am Heart J. 2014;168:792–797.CrossRefPubMed Leoncini M, Toso A, Maioli M, et al. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Am Heart J. 2014;168:792–797.CrossRefPubMed
Metadata
Title
Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
Authors
M. Verdoia
A. Schaffer
L. Barbieri
G. Di Giovine
G. Bellomo
P. Marino
H. Suryapranata
G. De Luca
Publication date
01-07-2016
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 7-8/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-016-0850-6

Other articles of this Issue 7-8/2016

Netherlands Heart Journal 7-8/2016 Go to the issue